CD4 and infection: The approach of using the BED-CEIA assay and CD4<200 cells/μl and VL<400 copies/mL as surrogate markers for FPR may facilitate the identification of recent infections in situ using the HIV monitoring tools already available or being scaled up in many low income countries.